Epigenetics in non-small cell lung cancer: from basics to therapeutics - Wikidata - awgldk - TriplyDB

Epigenetics in non-small cell lung cancer: from basics to therapeutics

Epigenetics in non-small cell lung cancer: from basics to therapeutics

http://www.wikidata.org/entity/Q26749113

about

Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells.The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.The liquid biopsy in lung cancer Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer.Sulforaphane Induced Apoptosis via Promotion of Mitochondrial Fusion and ERK1/2-Mediated 26S Proteasome Degradation of Novel Pro-survival Bim and Upregulation of Bax in Human Non-Small Cell Lung Cancer Cells The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo.Efficacy and safety of nivolumab combined with standard therapies for first-line therapy of advanced non-small cell lung cancer.Overexpression of RAD51B predicts a preferable prognosis for non-small cell lung cancer patients.Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer.Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells.Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers TdIF1: a putative oncogene in NSCLC tumor progression The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

P2860

Q33815839-48AB2395-3A41-4FC0-BBDF-C5FCDE9F7CF8 Q33829495-94E86D0A-B03A-4EDD-B9E0-B3C5C9D705AA Q33852030-180BE1FF-3C77-46D9-AA58-69719FB7DEFC Q37731703-2E874D7B-B9B3-4A7A-A856-869BCE27FE85 Q39132753-C83AAC88-F9FA-4117-AD23-A55115ED30DE Q40070868-23297237-D280-4E60-ACEA-9F9F772F16F7 Q41235504-FABA98BE-9048-4929-AAE8-9A8C7331AAD2 Q41243369-111FD8D0-60E8-47FE-B89A-A49996F0790D Q41708839-3C9BFA58-E70C-433E-819A-B15311513762 Q42369265-A6B50098-3977-4067-9A28-4B966A38B646 Q47105602-D1BFBC3E-995B-4DFA-9BE7-0BEA8EAC8669 Q47107660-44DC9D52-7146-460C-9C7F-B2314C966BA8 Q47807283-A5264B04-30C2-4A98-BF6C-B01844765D81 Q49181173-B5FB8906-8A65-403B-BF9D-0AC6F812F312 Q55161381-AED22A5F-135C-4300-AE9D-7D6B1F4DA181 Q56892179-45B29C96-E63F-4C3C-90EE-E1A6CB47BE4A Q57811691-45D3BDEB-B5B8-46D7-B83D-AF2A21AC9640 Q57816535-1A52FA08-3D0C-42F2-995C-8F1D074568CB

P2860

Epigenetics in non-small cell lung cancer: from basics to therapeutics

http://www.wikidata.org/entity/Q26749113

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@ast

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@en

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@nl

type

label

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@ast

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@en

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@nl

prefLabel

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@ast

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@en

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@nl

P1433

Q26749113-F6F97DD0-F5D9-49CC-ADD0-5A62B59A811F

P1476

Q26749113-64740FBA-406A-406D-A890-213EC1817B95

P2093

Q26749113-3BF41953-2415-48D2-8230-0B4EFEABCAC5

Q26749113-57F6AC8F-ACED-486B-89B8-C6BC2B68A4AD

Q26749113-B6B530FF-CD63-4EE7-A6B5-6CD7AF13A0CD

P2860

Q26749113-0130FD71-A56E-43FD-BB19-4FF1F57901EE

Q26749113-02A7CE26-85EF-4908-9BEF-A0EB8EBDFD29

Q26749113-03A48699-3B15-40FA-B8C8-4C295751F78F

Q26749113-061966C3-22E2-4BA7-9053-2AA8D2004B2C

Q26749113-0C98E0AD-3158-49D7-BD5B-6E08C142530F

Q26749113-0DA117D2-F20D-4833-B71B-1553D946724F

Q26749113-0DD105C4-954F-4672-91E8-13C203907621

Q26749113-0EB00377-A645-4AD4-AB61-4978EED5E7BA

Q26749113-0F0C91F1-FB2B-4D9B-8BA5-466A3E99C3C7

Q26749113-117B48C3-C078-44E8-AD21-5E89B5C7EEEB

P304

Q26749113-F568088E-3346-4FBD-9E66-442CA46ED97B

P31

Q26749113-44282bd6-6d73-471f-ae41-15e8e33ee415

Q26749113-DFF5C091-3DA2-4240-A48A-A29FD95E0CD6

P3181

Q26749113-E25DAF25-4B91-4534-BEE5-DB4E7F28CE24

P356

Q26749113-B76EC56F-B73C-4228-86DA-CB3994A3E0F8

P407

Q26749113-9B6E0EF0-4A8F-4A99-B966-7EBB257E3922

P433

Q26749113-4D86116B-B13C-49DB-9DB9-3F273A0B6DE7

P478

Q26749113-559183DF-BF2D-4498-8702-841BAAB7C31D

P577

Q26749113-F736DE5F-B325-4C0C-8473-151B3B9BD9C6

P5875

Q26749113-4CEF7315-E679-49A6-8988-64F1B7726853

P698

Q26749113-BE1D4F8B-3AC5-48AB-A4FE-105CA273787E

P932

Q26749113-97326BEA-3385-45C1-9FCA-2E2D6D862E6F

P3181

P356

TLCR.2016.02.02

P1433

Translational lung cancer research

P1476

Epigenetics in non-small cell lung cancer: from basics to therapeutics

@en

P2093

Hazem El-Osta

http://www.w3.org/2001/XMLSchema#string

Junaid Ansari

http://www.w3.org/2001/XMLSchema#string

Rodney E Shackelford

http://www.w3.org/2001/XMLSchema#string

P2860

SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates

The DNA sequence and analysis of human chromosome 6

Crystal structure of the nucleosome core particle at 2.8 A resolution

EUKARYOTIC CYTOSINE METHYLTRANSFERASES

Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

DNA methylation profiling of human chromosomes 6, 20 and 22

Circulating microRNAs as stable blood-based markers for cancer detection.

P304

155-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3727504

http://www.w3.org/2001/XMLSchema#string

P356

10.21037/TLCR.2016.02.02

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301709071

http://www.w3.org/2001/XMLSchema#string

P698

27186511

http://www.w3.org/2001/XMLSchema#string

P932

4858572

http://www.w3.org/2001/XMLSchema#string